Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed. This appears to be a minor version-label update and does not modify study content or functionality.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.4.3 has been added, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.4.2 was added; the prior Notice about government funding lapse and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check69 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1. These changes are cosmetic and do not alter the study content.SummaryDifference0.2%

- Check76 days agoChange DetectedMinor UI/text tweaks were made: a glossary display option, capitalization updates for QC-related fields and No FEAR Act data, and a new revision tag (v3.4.0). These edits do not affect study content, eligibility criteria, results, or user workflow.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision history updated: added Revision v3.3.4 and removed Revision v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.